Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (28)
Kyeong-Mee Park, Namkwon Lee, Jaeyeon Kim, Hyun Sil Kim & Wonse Park. (2023) Preventive effect of teriparatide on medication-related osteonecrosis of the jaw in rats. Scientific Reports 13:1.
Crossref
Crossref
Qiuling Wang, Qingzhen Yu, Ping Zeng & Weipeng Ai. (2023) Efficacy and Safety of Annual Infusion of Zoledronic Acid and Weekly Oral Alendronate in the Treatment of Primary Osteoporosis: A Meta‐Analysis. The Journal of Clinical Pharmacology 63:4, pages 455-465.
Crossref
Crossref
Cristiana Gomes Rebelo, Juliana Campos Hasse Fernandes, Nuno Bernardo, Patrícia Couto & Gustavo Vicentis Oliveira Fernandes. (2023) Bisphosphonates and Their Influence on the Implant Failure: A Systematic Review. Applied Sciences 13:6, pages 3496.
Crossref
Crossref
Sugandha Gupta, Preeti Singh, Parul Verma, Malvika Chaudhary & Sajid Ali. 2023. Functional Nanocomposite Hydrogels. Functional Nanocomposite Hydrogels
541
557
.
Qin Hu, Xun Pan, Yaxian Liang, Hongdan Xu, Jinning Gu, Wenting She & Huixu Xie. (2022) Comparative efficacy and safety of bisphosphonate therapy for bone loss in individuals after middle age: A systematic review and network meta-analysis. Nano TransMed 1:1, pages 9130003.
Crossref
Crossref
Erika Baum. 2022. Facharzt Allgemeinmedizin. Facharzt Allgemeinmedizin
533
538
.
Carl Hoefer & Alexander Krauss. (2021) Measures of effectiveness in medical research: Reporting both absolute and relative measures. Studies in History and Philosophy of Science 88, pages 280-283.
Crossref
Crossref
D. Sanchez-Rodriguez, P. Bergmann, J.J. Body, E. Cavalier, E. Gielen, S. Goemaere, B. Lapauw, MR Laurent, S. Rozenberg, G. Honvo, C. Beaudart & O. Bruyère. (2020) The Belgian Bone Club 2020 guidelines for the management of osteoporosis in postmenopausal women. Maturitas 139, pages 69-89.
Crossref
Crossref
Feng-Chen Kao, Yao-Chun Hsu, Tzu-Shan Chen, Yuan-Kun Tu & Pao-Hsin Liu. (2020) Effects of Injected Antiosteoporotic Medication Versus Oral Bisphosphonates on Rates of Repeated Vertebroplasty or Kyphoplasty. Clinical Therapeutics 42:6, pages 1087-1098.e2.
Crossref
Crossref
Liqing Lu, Lifen Lu, Jianping Zhang & Jian Li. (2019) Potential risks of rare serious adverse effects related to long‐term use of bisphosphonates: An overview of systematic reviews. Journal of Clinical Pharmacy and Therapeutics 45:1, pages 45-51.
Crossref
Crossref
Theodora Papamitsou, Antonios Morsi-Yeroyannis, Anastasios Papanastasiou, Nikolaos Bakalopoulos, Eva-Maria Dietrich, Sofia Karachrysafi, Alexandros Toskas, Evangelia Mareti, Anastasia Morsi-Yeroyanni & Antonia Sioga. (2020) Bisphosphonate’s Effect on Tongue Mucosa: An Experimental Electron Microscopy Study. Medicina 56:2, pages 51.
Crossref
Crossref
Melanie Fischbacher, Benjamin K Weeks & Belinda R Beck. (2019) The influence of antiresorptive bone medication on the effect of high-intensity resistance and impact training on osteoporotic fracture risk in postmenopausal women with low bone mass: protocol for the MEDEX-OP randomised controlled trial. BMJ Open 9:9, pages e029895.
Crossref
Crossref
Saima Zameer, Abul Kalam Najmi, Divya Vohora & Mohd Akhtar. (2018) Bisphosphonates: Future perspective for neurological disorders. Pharmacological Reports 70:5, pages 900-907.
Crossref
Crossref
Ki‐Yeol Kim, Xianglan Zhang & In‐Ho Cha. (2017) Identifying a combined biomarker for bisphosphonate‐related osteonecrosis of the jaw. Clinical Implant Dentistry and Related Research 20:2, pages 191-198.
Crossref
Crossref
P. J. M. Elders, T. Merlijn, K. M. A. Swart, W. van Hout, B. C. van der Zwaard, C. Niemeijer, M. W. Heymans, A. A. van der Heijden, F. Rutters, H. E. van der Horst, P. Lips, J. C. Netelenbos & N. M. van Schoor. (2017) Design of the SALT Osteoporosis Study: a randomised pragmatic trial, to study a primary care screening and treatment program for the prevention of fractures in women aged 65 years or older. BMC Musculoskeletal Disorders 18:1.
Crossref
Crossref
Linda Karlsson, Johan Mesterton, Maurille Feudjo Tepie, Michele Intorcia, Jetty Overbeek & Oskar Ström. (2017) Exploring methods for comparing the real-world effectiveness of treatments for osteoporosis: adjusted direct comparisons versus using patients as their own control. Archives of Osteoporosis 12:1.
Crossref
Crossref
G. Wang, L. Sui, P. Gai, G. Li, X. Qi & X. Jiang. (2017) The efficacy and safety of vertebral fracture prevention therapies in post-menopausal osteoporosis treatment. Bone & Joint Research 6:7, pages 452-463.
Crossref
Crossref
Nikos Mardas, Juliano Busetti, José Antonio Poli de Figueiredo, Luis André Mezzomo, Roberta Kochenborger Scarparo & Nikolaos Donos. (2017) Guided bone regeneration in osteoporotic conditions following treatment with zoledronic acid. Clinical Oral Implants Research 28:3, pages 362-371.
Crossref
Crossref
Liwei Yao, Haiqing Wang, Wenwei Dong, Zhenxin Liu & Haijiao Mao. (2017) Efficacy and safety of bisphosphonates in management of low bone density in inflammatory bowel disease. Medicine 96:3, pages e5861.
Crossref
Crossref
S Yu Vorotnikova & E A Pigarova. (2016) ZOLEDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS AND OTHER SKELETAL DISORDERS. Osteoporosis and Bone Diseases 19:3, pages 23-27.
Crossref
Crossref
Fang Lv, Yi Liu, Xiaojie Xu, Jianyi Wang, Doudou Ma, Yan Jiang, Ou Wang, Weibo Xia, Xiaoping Xing, Wei Yu & Mei Li. (2016) Effects of Long-Term Alendronate Treatment on a Large Sample of Pediatric Patients with Osteogenesis Imperfecta. Endocrine Practice 22:12, pages 1369-1376.
Crossref
Crossref
Mohammed-Salleh M. Ardawi, Mohammed H. Badawoud, Sherif M. Hassan, Abdulrahim A. Rouzi, Jumanah M.S. Ardawi, Nouf M. AlNosani, Mohammed H. Qari & Shaker A. Mousa. (2016) Lycopene treatment against loss of bone mass, microarchitecture and strength in relation to regulatory mechanisms in a postmenopausal osteoporosis model. Bone 83, pages 127-140.
Crossref
Crossref
Eric Kai-Chung Wong, Lisa Ha-Yeon Kim & Alexandra Papaioannou. 2016. Osteoporosis in Older Persons. Osteoporosis in Older Persons
201
214
.
Pei-ran Zhou, Xiao-jie Xu, Zhen-lin Zhang, Er-yuan Liao, De-cai Chen, Jian Liu, Wen Wu, Yan Jiang, Ou Wang, Wei-bo Xia, Xiao-ping Xing, Ling Xu & Mei Li. (2015)
SOST
polymorphisms and response to alendronate treatment in postmenopausal Chinese women with osteoporosis
. Pharmacogenomics 16:10, pages 1077-1088.
Crossref
Crossref
Ling-Xiao Chen, Zhi-Rui Zhou, Yu-Lin Li, Guang-Zhi Ning, Tian-Song Zhang, Di Zhang & Shi-Qing Feng. (2015) Comparison of Bone Mineral Density in Lumbar Spine and Fracture Rate among Eight Drugs in Treatments of Osteoporosis in Men: A Network Meta-Analysis. PLOS ONE 10:5, pages e0128032.
Crossref
Crossref
M De Santis, F Cavaciocchi, A Ceribelli, C Crotti, E Generali, G Fabbriciani, C Selmi & M Massarotti. (2015) Gamma-delta T lymphocytes and 25-hydroxy vitamin D levels as key factors in autoimmunity and inflammation: the case of zoledronic acid-induced acute phase reaction. Lupus 24:4-5, pages 442-447.
Crossref
Crossref
Emma M. Clark & Darshana Durup. (2015) Inflammatory eye reactions with bisphosphonates and other osteoporosis medications: what are the risks?. Therapeutic Advances in Musculoskeletal Disease 7:1, pages 11-16.
Crossref
Crossref
Weiwei Zhang, Chen Zhu, Mengwen Sun, Yuhao Ge & Guang Yan. (2014) RETRACTED: Efficacy of Bisphosphonates against Hip Fracture in Elderly Patients with Stroke and Parkinson Diseases: Meta-analysis of Randomized Controlled Trials. Journal of Stroke and Cerebrovascular Diseases 23:10, pages 2714-2724.
Crossref
Crossref